{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T16:06:36Z","timestamp":1779120396677,"version":"3.51.4"},"reference-count":20,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T00:00:00Z","timestamp":1779062400000},"content-version":"unspecified","delay-in-days":137,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Neurol Open"],"accepted":{"date-parts":[[2026,5,4]]},"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Longitudinally extensive transverse myelitis (LETM) is a severe inflammatory spinal cord disorder. It is commonly associated with neuromyelitis optica spectrum disorders and other autoimmune conditions like Sj\u00f6gren syndrome, infectious and idiopathic aetiologies. Interleukin-6 (IL-6) is one of the key pro-inflammatory cytokines implicated in neuroinflammation and may serve as an important biomarker of disease activity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To evaluate the correlation between cerebrospinal fluid (CSF) IL-6 levels and disease activity in patients with LETM and to assess its prognostic value for short-term functional outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this prospective follow-up study conducted over 18 months, 41 patients with LETM and 21 controls with non-inflammatory neurological conditions were enrolled. Disease severity was assessed using the Expanded Disability Status Scale (EDSS) at admission and at 3-month follow-up. CSF IL-6 levels were analysed and correlated with clinical and radiological variables using Spearman correlation, receiver operating characteristic (ROC) analysis and multivariate regression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Median CSF IL-6 levels were significantly higher in LETM patients than controls (11.26 vs 5.02\u2009pg\/mL; p&lt;0.001). CSF IL-6 showed a moderate positive correlation with EDSS at admission (\u03c1=0.34, p=0.027) and follow-up (\u03c1=0.51, p&lt;0.001). ROC analysis demonstrated fair predictive accuracy for severe disease (AUC=0.70), with a cut-off of approximately 7\u2009pg\/mL. Multivariate analysis identified CSF IL-6 as an independent predictor of disease severity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>CSF IL-6 correlates with disease activity and disability in LETM and may serve as a useful biomarker for prognostication and treatment planning.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjno-2026-001593","type":"journal-article","created":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T15:10:27Z","timestamp":1779117027000},"page":"e001593","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Correlation of cerebrospinal fluid IL-6 as a marker of disease activity in patients with longitudinally extensive transverse myelitis"],"prefix":"10.1136","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-3052-2969","authenticated-orcid":false,"given":"Sangam","family":"Singh","sequence":"first","affiliation":[{"name":"Neurology, Dr Ram Manohar Lohia Institute of Medical Sciences, Lucknow, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ajai Kumar","family":"Singh","sequence":"additional","affiliation":[{"name":"Neurology, Dr Ram Manohar Lohia Institute of Medical Sciences, Lucknow, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pradeep Kumar","family":"Maurya","sequence":"additional","affiliation":[{"name":"Neurology, Dr Ram Manohar Lohia Institute of Medical Sciences, Lucknow, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manish","family":"Kulshreshtha","sequence":"additional","affiliation":[{"name":"Biochemistry, Dr Ram Manohar Lohia Institute of Medical Sciences, Lucknow, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dinkar","family":"Kulshreshtha","sequence":"additional","affiliation":[{"name":"Neurology, Dr Ram Manohar Lohia Institute of Medical Sciences, Lucknow, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdul","family":"Qavi","sequence":"additional","affiliation":[{"name":"Neurology, Dr Ram Manohar Lohia Institute of Medical Sciences, Lucknow, India"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2026,5,18]]},"reference":[{"key":"2026051808101627000_8.1.e001593.1","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1212\/WNL.31.8.966","article-title":"Acute transverse myelitis: incidence and etiologic considerations","volume":"31","author":"Berman","year":"1981","journal-title":"Neurology (ECronicon)"},{"key":"2026051808101627000_8.1.e001593.2","doi-asserted-by":"publisher","DOI":"10.1177\/1352458511406165"},{"key":"2026051808101627000_8.1.e001593.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2009.12.007"},{"key":"2026051808101627000_8.1.e001593.4","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1212\/WNL.59.4.499","article-title":"Proposed diagnostic criteria and nosology of acute transverse myelitis","volume":"59","year":"2002","journal-title":"Neurology (ECronicon)"},{"key":"2026051808101627000_8.1.e001593.5","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.jns.2016.12.033","article-title":"Longitudinally extensive transverse myelitis immune-mediated in aquaporin-4 antibody negative patients: Disease heterogeneity","volume":"373","author":"Carnero Contentti","year":"2017","journal-title":"J Neurol Sci"},{"key":"2026051808101627000_8.1.e001593.6","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.cca.2017.03.006","article-title":"Interleukin-6 analysis of 572 consecutive CSF samples from neurological disorders: A special focus on neuromyelitis optica","volume":"469","author":"Uzawa","year":"2017","journal-title":"Clin Chim Acta"},{"key":"2026051808101627000_8.1.e001593.7","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1212\/WNL.53.5.1107","article-title":"The clinical course of neuromyelitis optica (Devic\u2019s syndrome)","volume":"53","author":"Wingerchuk","year":"1999","journal-title":"Neurology (ECronicon)"},{"key":"2026051808101627000_8.1.e001593.8","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(20)30070-3"},{"key":"2026051808101627000_8.1.e001593.9","doi-asserted-by":"crossref","unstructured":"Kanikannan MA , Reddy PK , Bejawada K , et al . A characteristic analysis of longitudinally extensive transverse myelitis in South Indian population: A cohort study. Neurol Asia 2018. doi:10.4103\/aian.AIAN_387_17","DOI":"10.4103\/aian.AIAN_387_17"},{"key":"2026051808101627000_8.1.e001593.10","doi-asserted-by":"crossref","first-page":"577456","DOI":"10.1016\/j.jneuroim.2020.577456","article-title":"Etiological spectrum, clinico-radiological profile and treatment outcomes of longitudinally extensive transverse myelitis - A prospective study from Northwest India","volume":"351","author":"Choudhary","year":"2021","journal-title":"J Neuroimmunol"},{"key":"2026051808101627000_8.1.e001593.11","article-title":"The Prevalence of Autoimmune Disorders in Women: A Narrative Review","volume":"12","author":"Angum","year":"2020","journal-title":"Cureus"},{"key":"2026051808101627000_8.1.e001593.12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2009.03.005"},{"key":"2026051808101627000_8.1.e001593.13","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.clineuro.2016.06.011","article-title":"Longitudinally extensive transverse myelitis: A retrospective analysis of sixty-four patients at tertiary care center of North-West India","volume":"148","author":"Jain","year":"2016","journal-title":"Clin Neurol Neurosurg"},{"key":"2026051808101627000_8.1.e001593.14","doi-asserted-by":"publisher","DOI":"10.1038\/ni0901-777"},{"key":"2026051808101627000_8.1.e001593.15","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.4103\/0028-3886.294544","article-title":"Study of Clinicoradiological Profile and Prognosis of Longitudinally Extensive Transverse Myelitis from a Single Tertiary Center in Eastern India","volume":"68","author":"Sahoo","year":"2020","journal-title":"Neurol India"},{"key":"2026051808101627000_8.1.e001593.16","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1212\/01.WNL.0000148481.80152.BF","article-title":"Activation of humoral immunity and eosinophils in neuromyelitis optica","volume":"63","author":"Correale","year":"2004","journal-title":"Neurology (ECronicon)"},{"key":"2026051808101627000_8.1.e001593.17","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.4666"},{"key":"2026051808101627000_8.1.e001593.18","doi-asserted-by":"crossref","unstructured":"Intrathecal activation of the il-17\/il-8 axis in opticospinal multiple sclerosis | brain | Oxford academic. 2025. Available: https:\/\/academic.oup.com\/brain\/article-abstract\/128\/5\/988\/278464?redirectedFrom=fulltext","DOI":"10.1093\/brain\/awh453"},{"key":"2026051808101627000_8.1.e001593.19","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000841","article-title":"Interleukin-6 in neuromyelitis optica spectrum disorder pathophysiology","volume":"7","author":"Fujihara","year":"2020","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"2026051808101627000_8.1.e001593.20","doi-asserted-by":"crossref","first-page":"100255","DOI":"10.1016\/j.nerep.2025.100255","article-title":"Longitudinally extensive transverse myelitis: Etiologies and common diagnostic pitfalls","volume":"7","author":"Abbas","year":"2025","journal-title":"Neuroimmunology Reports"}],"container-title":["BMJ Neurology Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjno-2026-001593","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T15:10:37Z","timestamp":1779117037000},"score":1,"resource":{"primary":{"URL":"https:\/\/neurologyopen.bmj.com\/lookup\/doi\/10.1136\/bmjno-2026-001593"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":20,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,5,18]]},"published-print":{"date-parts":[[2026,1]]}},"alternative-id":["10.1136\/bmjno-2026-001593"],"URL":"https:\/\/doi.org\/10.1136\/bmjno-2026-001593","relation":{},"ISSN":["2632-6140"],"issn-type":[{"value":"2632-6140","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]}}}